Adverse reactions to medical drugs cause thousands of deaths in the UK every year. Statins, aspirin and other drugs are taken en masse, whether they help or harm. Our one-size-fits-all approach to medicine is primitive. Who we are - our age, gender, size, ethnic group, environmental conditions, our very individuality - matters to our health. Shouldn't our medicine be tailored to our differences? With an introduction by Dr Angeli Mehta explaining the British perspective, this book explores these groundbreaking advances and the coming sea change in how we detect and treat disease. It also discusses the other issues we will face: Who will have access to the highly sensitive data? Who will fund research when mass prescription drugs are finished? This important new book will help us wake up to taking charge of our health in a completely new era.
Rezensionen / Stimmen
"Essential reading for anyone - from the novice to the insider - who is seeking to understand how medicine is changing." -- Luke Timmerman, biotechnology journalist. "Cullis will enlighten you as to why personalized medicine will be the greatest technological advance you have ever experienced." -- Rob Wright, Life Science Leader. "This is a must-read for anyone who wants a glimpse into medicine's potentially revolutionary future." -- Tom Blackwell, The National Post.
Sprache
Verlagsort
Verlagsgruppe
Maße
Höhe: 216 mm
Breite: 135 mm
ISBN-13
978-1-908643-95-7 (9781908643957)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Klassifikation
Pieter Cullis's research has already led to fundamental advances in the treatment of cancer. He is Director of the Life Sciences Institute at the University of British Columbia and Chairman of the B.C. Personalized Medicine Initiative. He is a Fellow of the Royal Society of Canada.
